FDA Chief Backs Streamlined Studies To Curb Drug Costs
Gottlieb made the comments at a Regulatory Affairs Professionals Society conference in Washington, D.C. The comments marked the latest in a string of moves that Gottlieb has announced to tackle soaring drug prices during his four months as FDA chief.
The commissioner prefaced his remarks by...
To view the full article, register now.